Most people with peritoneal cancer have other cancers that have spread. Doctors only diagnose the disease in the advanced stages, so the prognosis can be short in some individuals. However, survival ...

Hyperthermic intraperitoneal chemotherapy (HIPEC) provides an important treatment option that can improve survival for some patients with advanced peritoneal cancer. Managing this disease — and ...

Peritoneal cancer is difficult to treat and has a poor survival prognosis. But a new and effective nanomedicine delivery system is offering some hope. The company is called NaDeNo and is well underway ...

PPC is a type of cancer that starts in the peritoneal cavity in the abdomen, rather than cancer that has developed elsewhere in the body and spread to the peritoneum. Cancer that has started elsewhere ...

Elahere is a type of targeted therapy called an antibody-drug conjugate. This antibody-drug conjugate is made up of an antibody that is attached to a cancer medicine. Elahere is used to treat a type ...

Peritoneal cancer is a rare cancer that starts in the thin tissue lining the abdomen. Symptoms often appear late and can include abdominal pain, swelling, and feeling full quickly after eating.

Malignant peritoneal mesothelioma is a rare and aggressive cancer that develops in the lining around the abdominal organs. Doctors usually treat it with surgery and chemotherapy. Peritoneal ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family ...